F. B. Cakir Et Al. , "False Positivity of Gallium-68 Dota-Octreotid PET/MR Secondary to cis-Retinoic Asid Treatment in a Patient with Neuroblastoma," PEDIATRIC BLOOD & CANCER , vol.65, 2018
Cakir, F. B. Et Al. 2018. False Positivity of Gallium-68 Dota-Octreotid PET/MR Secondary to cis-Retinoic Asid Treatment in a Patient with Neuroblastoma. PEDIATRIC BLOOD & CANCER , vol.65 .
Cakir, F. B., Besli, L. U., & Kiran, T., (2018). False Positivity of Gallium-68 Dota-Octreotid PET/MR Secondary to cis-Retinoic Asid Treatment in a Patient with Neuroblastoma. PEDIATRIC BLOOD & CANCER , vol.65.
Cakir, F., L. Uslu Besli, And T. Kiran. "False Positivity of Gallium-68 Dota-Octreotid PET/MR Secondary to cis-Retinoic Asid Treatment in a Patient with Neuroblastoma," PEDIATRIC BLOOD & CANCER , vol.65, 2018
Cakir, F. B. Et Al. "False Positivity of Gallium-68 Dota-Octreotid PET/MR Secondary to cis-Retinoic Asid Treatment in a Patient with Neuroblastoma." PEDIATRIC BLOOD & CANCER , vol.65, 2018
Cakir, F. B. Besli, L. U. And Kiran, T. (2018) . "False Positivity of Gallium-68 Dota-Octreotid PET/MR Secondary to cis-Retinoic Asid Treatment in a Patient with Neuroblastoma." PEDIATRIC BLOOD & CANCER , vol.65.
@article{article, author={F. B. Cakir Et Al. }, title={False Positivity of Gallium-68 Dota-Octreotid PET/MR Secondary to cis-Retinoic Asid Treatment in a Patient with Neuroblastoma}, journal={PEDIATRIC BLOOD & CANCER}, year=2018}